| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Monte Rosa Therapeutics, Inc.'s insiders have reduced their positions by a net 13 shares worth roughly $137. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale. Classified under Biotechnology (Health Care sector), GLUE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.69M | - | - | |
| CEO | 585.0K | $13.56M | - | |
| Other | 67.8K | $1.58M | - | |
| COO | 62.4K | $248.2K | - | |
| Other | 60.6K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Bowen Matthew | Principal Accounting Officer | Sell | 13 | $10.56 | $137.28 | - | - | - | |
| Jul 16, 2026 | Warmuth Markus | President &CEO | Sell | 9,500 | $23.18 | $220,218.55 | -1.6% | -57.5% | - | |
| Jul 15, 2026 | Champoux Jennifer | Chief Operating Officer | Sale+OE10b5-1 | 4,351 | $23.38 | $101,729.86 | -6.5% | -57.8% | - | |
| Jul 6, 2026 | Townson Sharon | Chief Scientific Officer | Sale+OE10b5-1 | 6,000 | $23.31 | $139,849.20 | -8.1% | -55.8% | - | |
| Jun 30, 2026 | Janku Filip | Chief Medical Officer | Sale+OE10b5-1 | 5,407 | $24.50 | $132,471.50 | -8.2% | -51.6% | - | |
| Jun 29, 2026 | Janku Filip | Chief Medical Officer | Sale+OE10b5-1 | 6,000 | $22.95 | $137,700.00 | -9.1% | -51.0% | - | |
| Jun 29, 2026 | Manning Anthony M. | Director | Sale+OE | 10,000 | $23.11 | $231,100.00 | - | -51.0% | - | |
| Jun 24, 2026 | Janku Filip | Chief Medical Officer | Sale+OE10b5-1 | 41,845 | $21.08 | $882,203.48 | -41.1% | -39.6% | - | |
| Jun 23, 2026 | Townson Sharon | Chief Scientific Officer | Sale+OE10b5-1 | 3,000 | $20.00 | $60,000.00 | -4.2% | -40.8% | - | |
| Jun 23, 2026 | Champoux Jennifer | Chief Operating Officer | Sale+OE10b5-1 | 2,175 | $20.00 | $43,500.00 | -3.4% | -40.8% | - |